3 studies found for:    19767093 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC)
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Pemetrexed;   Drug: Placebo;   Other: Best Supportive Care
2 Recruiting Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Lenalidomide
3 Not yet recruiting Phase III Open Label First Line Therapy Study of MEDI 4736 With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC).
Condition: Non-Small-Cell Lung Carcinoma (NSCLC)
Interventions: Biological: MEDI4736;   Biological: MEDI4736+Tremelimumab;   Drug: Paclitaxel + Carboplatin;   Drug: Gemcitabine + Cisplatin;   Drug: Gemcitabine + Carboplatin;   Drug: Pemetrexed + Cisplatin;   Drug: Pemetrexed + Carboplatin;   Biological: Tremelimumab

Indicates status has not been verified in more than two years